We are live on
!
Find out more
Arcutis Biotherapeutics
ARQT
ARQT
282 hedge funds and large institutions have $3.75B invested in Arcutis Biotherapeutics in 2025 Q4 according to their latest regulatory filings, with 73 funds opening new positions, 103 increasing their positions, 77 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
712% more call options, than puts
Call options by funds: $21.1M | Put options by funds: $2.6M
192% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 25
58% more capital invested
Capital invested by funds: $2.37B → $3.75B (+$1.37B)
34% more repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 77
18% more funds holding
Funds holding: 239 → 282 (+43)
0.46% more ownership
Funds ownership: 104.93% → 105.4% (+0.46%)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
282
Holders Change
+43
Holders Change %
+17.99%
% of All Funds
3.43%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.05%
New
73
Increased
103
Reduced
77
Closed
25
Calls
$21.1M
Puts
$2.6M
Net Calls
+$18.5M
Net Calls Change
+$10.4M
